As the world awaits the development of a vaccine for the novel coronavirus causing Covid-19, reports in the past week of successful treatment of severely ill patients at a Chicago hospital with the antiviral medicine Remdesivir were headlined in the US and caused a bounce on global sharemarkets.
Remdesivir was one of the first medicines identified in lab tests as having the potential to impact SARS-CoV-2. Results from US biotechnology firm Gilead Science’s clinical trials have been eagerly expected as the world looks for positive outcomes which could lead to fast approvals by the Food and Drug Administration and other regulatory agencies.
If safe and effective, it could become the first approved treatment against the disease.
The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease.
All the patients have been treated with daily infusions of…
View original post 697 more words

TOMKINS COVE , NY – MAY 11: The Indian Point nuclear power plant is seen from Tomkins Cove, New York … [+] CORBIS VIA GETTY IMAGES But the premature closure of the 2,069-megawatt nuclear plant is even worse land-use policy. Here’s why: replacing the 16 terawatt-hours of carbon-free electricity that is now being produced by the twin-reactor plant with wind turbines will require 1,300 times as much…
Coverage in Searchlight (May 2000) 
Recent Comments